NACC1 and acute myeloid leukemia: The abnormal expression of NACC1 modulated the expression of ADAM9, subsequently activating the PI3K/AKT axis, enhancing the proliferation of AML cells, accelerating cell cycle progression, and inhibiting apoptosis.